文献速递癫痫

新西兰儿童治疗性癫痫的流行病学:聚焦种族差异

Epidemiology of Treated Epilepsy in New Zealand Children: A Focus on Ethnicity.
PubMed 文献 · Neurology · 2021-09-09

该回顾性队列研究基于新西兰药品收集数据库,纳入2015年≤18岁且配取抗癫痫发作药物(ASM)的儿童,覆盖全国48%儿童人口,经病历复核确认癫痫诊断。治疗性癫痫期间患病率为3.4/1000儿童;最贫困地区儿童患病率为最不贫困地区的1.9倍(95%CI 1.6-2.2);亚洲儿童患病率较低(2.3/1000,95%CI 2.0-2.6),但调整社会经济剥夺后欧洲裔最高,毛利、太平洋岛民和亚洲儿童相近。

要点

  • 治疗性癫痫期间患病率为3.4/1000儿童。
  • 最贫困地区儿童患病率为最不贫困地区的1.9倍(95%CI 1.6-2.2)。
  • 调整社会经济剥夺后,欧洲裔儿童患病率最高。

核心结论

  • 治疗性癫痫患病率与 socioeconomic deprivation 相关,最贫困地区儿童患病率约为最不贫困地区的1.9倍。
  • 未调整时亚洲儿童患病率较低,但调整社会经济剥夺后欧洲裔最高,毛利、太平洋岛民和亚洲儿童相近。

研究设计与样本

  • 回顾性队列研究,检索新西兰药品收集数据库2015年≤18岁配取ASM的个体,覆盖48%新西兰儿童人口。
  • 共2594名儿童配取3557次ASM,其中1717名(66%)儿童确诊癫痫;3332/3557(94%)次ASM明确了处方指征。

主要发现

  • 治疗性癫痫期间患病率为3.4/1000儿童。
  • 最贫困地区儿童患病率为最不贫困地区的1.9倍(95%CI 1.6-2.2)。
  • 未调整患病率:欧洲/其他3.7(95%CI 3.4-3.9)、太平洋岛民3.6(95%CI 3.2-4.1)、毛利3.4(95%CI 3.1-3.8)、亚洲2.3/1000(95%CI 2.0-2.6)。
  • 调整社会经济剥夺后,欧洲裔儿童癫痫患病率最高,毛利、太平洋岛民和亚洲儿童相近。

临床怎么用

  • 在评估儿童癫痫患病率时需考虑社会经济剥夺的影响,尤其是贫困地区儿童。
  • 解读不同种族儿童癫痫患病率时应调整社会经济因素,避免未调整比较的误导。

局限性

  • 研究基于配取ASM且经病历复核确认的癫痫病例,可能未覆盖未治疗或未就医的癫痫患者。
  • 数据库覆盖新西兰48%儿童人口,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To determine the period prevalence and incidence of treated epilepsy in a New Zealand pediatric cohort with a focus on ethnicity and socioeconomic status. METHODS: This was a retrospective cohort study. The New Zealand Pharmaceutical Collection database was searched for individuals ≤18 years of age dispensed an antiseizure medication (ASM) in 2015 from areas capturing 48% of the New Zealand pediatric population. Medical records of identified cases were reviewed to ascertain the indication for the ASM prescription. Population data were derived from the New Zealand 2013 Census. RESULTS: A total of 3,557 ASMs were prescribed during 2015 in 2,594 children, of whom 1,717 (66%) children had epilepsy. An indication for prescription was ascertained for 3,332/3,557 (94%) ASMs. The period prevalence of treated epilepsy was 3.4 per 1,000 children. Children in the most deprived areas had 1.9 times the rate of treated epilepsy (95% confidence interval [CI] 1.6-2.2) as those from the least deprived areas. Prevalence was similar for most ethnic groups (European/other: 3.7, 95% CI 3.4-3.9; Pacific Peoples: 3.6, 95% CI 3.2-4.1; Māori: 3.4, 95% CI 3.1-3.8) apart from Asians, who had a lower prevalence of 2.3 per 1,000 (95% CI 2.0-2.6). However, when adjusted for socioeconomic deprivation, the prevalence of epilepsy was highest in European and similar in Māori, Pacific, and Asian children. DISCUSSION: This is the largest pediatric epidemiology epilepsy study where diagnosis of epilepsy was confirmed by case review. This is the first study to provide epidemiologic information for pediatric epilepsy in Māori and Pacific children.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ali S, Stanley J, Davis S, et al. Epidemiology of Treated Epilepsy in New Zealand Children: A Focus on Ethnicity. Neurology. 2021. PMID: 34504020. doi:10.1212/WNL.0000000000012784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。